Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 45
- News Article
- News Article PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer...
- 관리자
- 14 Jan 2019
- Views528
- 0
- 44
- News Article
- News Article PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer...
- Manager
- 14 Jan 2019
- Views679
- 1
- 43
- News Article
- News Article PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer...
- Manager
- 14 Jan 2019
- Views543
- 1
- 42
- News Article
- News Article PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is attending ASCO 2018.
- Manager
- 14 Jan 2019
- Views525
- 1
- 41
- News Article
- News Article PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer...
- 관리자
- 14 Jan 2019
- Views453
- 0
- 40
- News Article
- News Article PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer...
- Manager
- 14 Jan 2019
- Views494
- 1
- 39
- News Article
- News Article PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme.
- Manager
- 14 Jan 2019
- Views604
- 1
- 38
- News Article
- News Article `` Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model``...
- Manager
- 14 Jan 2019
- Views519
- 1